医学
恩替卡韦
内科学
脂肪性肝炎
胃肠病学
HBeAg
优势比
脂肪变性
肝活检
体质指数
置信区间
纤维化
病毒载量
减肥
脂肪肝
活检
乙型肝炎病毒
免疫学
肥胖
乙型肝炎表面抗原
拉米夫定
病毒
疾病
人类免疫缺陷病毒(HIV)
作者
Xiujuan Chang,Yiwen Shi,Jing Wang,Huabao Liu,Yan Chen,Xiaoning Zhu,Yong‐Ping Chen,Zujiang Yu,Qinghua Shang,Lin Tan,Qin Li,Jiang Li,Guangming Xiao,Liang Chen,Wei Lu,Xiaoyu Hu,Qinghua Long,Linjing An,Ziyuan Zou,Vincent Wai‐Sun Wong
标识
DOI:10.1016/j.hbpd.2021.06.009
摘要
Lower BMI and weight reduction but not virologic factors determine NASH resolution in CHB. The value of weight management in CHB patients during antiviral treatment deserves further evaluation.
科研通智能强力驱动
Strongly Powered by AbleSci AI